Skip to main content
. 2020 Oct 21;10(4):182. doi: 10.3390/jpm10040182

Figure 1.

Figure 1

Schematic representation of the workflow. Plasma samples were collected from patients with spinal cord injury (SCI) with and without confirmed COVID-19 infection. The experimental design consists of a discovery phase using TMT labelling, followed by LC-MS/MS and a confirmation phase employing Western blotting (WB).